1. |
El-serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 1994, 132(7): 25571-2576.
|
2. |
林黎娟, 金政, 王研, 等. 超声引导下肝癌穿刺组织中 DEK 表达的临床意义. 辽东学院学报: 自然科学版, 2011, 18(1): 50-52, 58.
|
3. |
Ahmad M, Riley TR. Can one predict when ultrasound will be useful with percutaneous liver biopsy? Am J Gastroenterol, 2001, 96(2): 547-549.
|
4. |
欧阳茂, 李锡寿, 李会斌, 等. 肝穿刺活检经验总结——附 949 例分析. 上海医学, 1999, 22(3): 189.
|
5. |
丛文铭, 谭璐, 张树辉, 等. 肝癌免疫组化诊断谱的研究和应用. 中华肿瘤杂志, 2002, 24(6): 553-556.
|
6. |
闫伟伟, 黄昂, 李永纲, 等. CD34 和 CD117 在人肝癌组织中的表达及其临床意义. 中华肝脏病杂志, 2011, 19(8): 588-593.
|
7. |
左婷婷, 郑荣寿, 曾红梅, 等. 中国肝癌发病状况与趋势分析. 中华肿瘤杂志, 2015, 37(9): 691-696.
|
8. |
Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev, 2004, 5(2): 118-125.
|
9. |
But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol, 2008, 14(11): 1652-1656.
|
10. |
陈建国, 陆建华, 朱源荣, 等. 乙型肝炎病毒感染与肝癌发生的 31 年随访研究. 中华流行病学杂志, 2010, 31(7): 721-726.
|
11. |
Lau SK, Prakash S, Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol, 2002, 33(12): 1175-1181.
|
12. |
范公忍, 汪毅, 胡大荣. TSGF、AFP、SF 联合检测对原发性肝癌诊断意义的评价. 上海免疫学杂志, 2000, 20(5): 317-317.
|
13. |
丛文铭, 朱世能. 肝胆肿瘤诊断外科病理学. 上海: 上海科技教育出版社, 2002: 132-164.
|
14. |
Soresi M, Magliarisi C, Campagna P, et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res, 2003, 23(2C): 1747-1753.
|
15. |
Zimmerman RL, Logani S, Baloch Z. Evaluation of the CD34 and CD10 immunostains using a two-color staining protocol in liver fine-needle aspiration biopsies. Diagn Cytopathol, 2005, 32(2): 88-91.
|
16. |
Murakata LA, Ishak KG, Nzeako UC. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol, 2000, 13(8): 874-881.
|
17. |
Ohmori S, Shiraki K, Sugimoto K, et al. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol, 2001, 32(12): 1363-1370.
|